{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:47:05Z","timestamp":1790192825953,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1168-y","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T08:48:19Z","timestamp":1545036499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection \u2014is plasma exchange or eculizumab use necessary?"],"prefix":"10.1186","volume":"19","author":[{"given":"Ken","family":"Saida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"1168_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371:654\u201366.","journal-title":"N Engl J Med"},{"key":"1168_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","volume":"33","author":"D Kavanagh","year":"2013","unstructured":"Kavanagh D, Goodship TH, Richards A. Atypical hemolytic uremic syndrome. Semin Nephrol. 2013;33:508\u201330.","journal-title":"Semin Nephrol"},{"key":"1168_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00467-001-0798-6","volume":"17","author":"R Berner","year":"2002","unstructured":"Berner R, Krause MF, Gordjani N, Zipfel PF, Boehm N, Krueger M, et al. Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis. Pediatr Nephrol. 2002;17:190\u20132.","journal-title":"Pediatr Nephrol"},{"key":"1168_CR4","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00467-010-1449-6","volume":"25","author":"S Chaturvedi","year":"2010","unstructured":"Chaturvedi S, Licht C, Langlois V. Hemolytic uremic syndrome caused by Bordetella pertussis infection. Pediatr Nephrol. 2010;25:1361\u20134.","journal-title":"Pediatr Nephrol"},{"key":"1168_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31:15\u201339.","journal-title":"Pediatr Nephrol"},{"key":"1168_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/bjh.12718","volume":"164","author":"M Scully","year":"2014","unstructured":"Scully M, Goodship T. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol. 2014;164:759\u201366.","journal-title":"Br J Haematol"},{"key":"1168_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0378-1097(03)00132-0","volume":"220","author":"MG Barnes","year":"2003","unstructured":"Barnes MG, Weiss AA. Activation of the complement cascade by Bordetella pertussis. FEMS Microbiol Lett. 2003;220:271\u20135.","journal-title":"FEMS Microbiol Lett"},{"key":"1168_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10157-016-1276-6","volume":"20","author":"H Kato","year":"2016","unstructured":"Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, et al. Clinical guides for atypical hemolytic uremic syndrome in Japan. Clin Exp Nephrol. 2016;20:536\u201343.","journal-title":"Clin Exp Nephrol"},{"key":"1168_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011;6:60.","journal-title":"Orphanet J Rare Dis"},{"key":"1168_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ajkd.2012.07.028","volume":"61","author":"J Schmidtko","year":"2013","unstructured":"Schmidtko J, Peine S, El-Housseini Y, Pascual M, Meier P. Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am J Kidney Dis. 2013;61:289\u201399.","journal-title":"Am J Kidney Dis"},{"key":"1168_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10096-006-0171-6","volume":"25","author":"I Pela","year":"2006","unstructured":"Pela I, Seracini D, Caprioli A, Castelletti F, Giammanco A. Hemolytic uremic syndrome in an infant following Bordetella pertussis infection. Eur J Clin Microbiol Infect Dis. 2006;25:515\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1168_CR12","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/INF.0b013e31826153fb","volume":"31","author":"I Obando","year":"2012","unstructured":"Obando I, Camacho MS, Falcon-Neyra D, Hurtado-Mingo A, Neth O. Atypical hemolytic uremic syndrome associated with Bordetella pertussis infection. Pediatr Infect Dis J. 2012;31:1210.","journal-title":"Pediatr Infect Dis J"},{"key":"1168_CR13","first-page":"456","volume":"14","author":"E Cohen-Ganelin","year":"2012","unstructured":"Cohen-Ganelin E, Davidovits M, Amir J, Prais D. Severe Bordetella pertussis infection associated with hemolytic uremic syndrome. Isr Med Assoc J. 2012;14:456\u20138.","journal-title":"Isr Med Assoc J"},{"key":"1168_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10157-015-1142-y","volume":"20","author":"N Ito","year":"2016","unstructured":"Ito N, Hataya H, Saida K, Amano Y, Hidaka Y, Motoyoshi Y, et al. Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan. Clin Exp Nephrol. 2016;20:265\u201372.","journal-title":"Clin Exp Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1168-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:08:12Z","timestamp":1576523292000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1168-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1168"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1168-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"23 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the National Center for Child Health and Development and the parental written informed consent was obtained for participation in this study and publication of data (IRB approval number 1614). This work was previously presented at the 17th IPNA Congress in Igua\u00e7u, Brazil.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written consent for publication was obtained from the parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests relevant to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"365"}}